Skip to main content

INCY Incyte Corporation

Healthcare

120.04 -0.35 -0.29% Close 11/2
Since 2024-12-02 +64.4%
Open
119.02
High
121.52
Low
118.25
Prev close
120.39
Volume
1.7M
Amplitude
2.72%
P/E
64.0
P/B
4.3
Revenue YoY (TTM)
+24.9%
52W 89.25 132.60

Is Incyte Corporation a buy? Fundamentals and valuation first

As of 2026-10-30

Quality: Good, Momentum: Good, Risk / liquidity: Strong; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but TTM P/E is Expensive.
TTM P/E 64.04 87th percentile Expensive
Price / book 4.35 80th percentile Pricey
Free-cash-flow yield (%) 2.79 57th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good All 3 indicators are Good.
ROE, TTM (%) 7.15 58th percentile Good
Operating margin, TTM (%) 11.61 58th percentile Good
FCF margin, TTM (%) 11.39 64th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Neutral Revenue growth, TTM YoY is Good, but Diluted EPS growth, TTM YoY is Average.
Revenue growth, TTM YoY (%) 24.88 78th percentile Good
Diluted EPS growth, TTM YoY (%) -68.51 29th percentile Average
Momentum Good All 2 indicators are Good.
60-day return (%) 1.7 74th percentile Good
240-day return (%) 15.59 68th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Strong 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 214,905,141 93th percentile Top
60-day annualized volatility (%) 27.47 31th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Incyte Corporation (INCY) today

1 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Incyte Corporation to every stock like it

AI finds several complementary traits of Incyte Corporation across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Incyte Corporation

Incyte Corporation (INCY) peers and tracking

Watchlist

This page refreshes daily after the close. Add Incyte Corporation to your watchlist to track signal changes on your next visit.

Incyte Corporation (INCY) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

EPS surprise beat

Active · now 8.4%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest
25 historical occurrences (since 2015-08-04)

Average forward return after EPS surprise beat

20-day: Win 50%, Sample 22, Median +0.43%, Excess +1.3%, Beat mkt rate 50%

60-day: Win 50%, Sample 22, Median -2.39%, Excess -1.51%, Beat mkt rate 45.5%

120-day: Win 61.9%, Sample 21, Median +7.04%, Excess +2.71%, Beat mkt rate 57.1%

120 days after: historical avg +8.59%

20-day +1.53%
60-day +0.4%
120-day +8.59%
20-day
60-day
120-day
Win
50%
50%
61.9%
Sample
22
22
21
Median
+0.43%
-2.39%
+7.04%
Excess
+1.3%
-1.51%
+2.71%
Beat mkt rate
50%
45.5%
57.1%

Over 21 occurrences, 120-day forward avg gained 8.59%, beat the market by 2.71 pts; win rate 61.9%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 128+25.5% +15.6% 100% +13.3%
20-40 222+7.7% +14.3% 73.9% -13.7%
40-60 99-6.1% -4.8% 27.3% -29.1%
60-80 You are here54-23% -23.9% 0% -48.3%
80-100 249+41.7% +42.8% 100% +23.8%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 64.04, placing it in the 76.0 own-history percentile, inside the 60-80 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+2.9%
Win rate 65.6% Excess -5%
250d
-4.3%
Win rate 22.4% Excess -18%
58d
Now
+7.3%
Win rate 47.6% Excess +2.8%
168d
60-day momentum down
+18.6%
Win rate 88.5% Excess +5.9%
156d
-9.8%
Win rate 11.4% Excess -19.1%
132d
+29.8%
Win rate 80% Excess +16.4%
100d

Currently in “Expensive (own-history top third) × 60-day momentum up”: across 168 historical days, 120-day forward avg gained 7.3%, win rate 47.6%, beat the market by 2.8%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

16 times historically; 60-day forward avg +1.67%, win rate 43.8%, beating the market by -2.87 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest

19 times historically; 60-day forward avg +4.49%, win rate 50%, beating the market by +0.56 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

15 times historically; 60-day forward avg +0.36%, win rate 46.7%, beating the market by -1.54 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.